4
Changes in Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0000950170-25-088496
Options or other derivatives
- Director acquired 22,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
GRAY SUSANNAH · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-06-17 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +22,500 | 22,500 | D |
Loading xslF345X05/ownership.xml…